Net Element, Inc. (NETE) Aims for the Millennial Generation and Beyond
Millennials, or ‘digital natives’, make up the generation of consumers on which many industries have focused their efforts for the…
Blog
Moxian, Inc. (MOXC) Rings Nasdaq Trade Opening Bell to Celebrate Uplisting
After a long journey in which no efforts were spared, China’s online-to-offline integrated social media operator, Moxian, Inc. (NASDAQ: MOXC),…
eXp World Holdings, Inc. (EXPI) Keeping Up-To-Date with Buyer Demographics
According to The National Association of Realtors (http://dtn.fm/Ct9j5), this October was the second month in a row to show incredible…
Axsome Therapeutics, Inc. (AXSM) Shedding New Light on Old Drugs
New York-based Axsome Therapeutics, Inc. (NASDAQ: AXSM) is tending to a major and thriving market where current treatment options are…
Monaker Group (MKGI) Tapping into Fast-Growing $200 Billion Millennial Travel Market
The travel industry is growing exponentially, but must also be ready to become more flexible and make more changes to…
OurPet’s Company (OPCO) is Growing Organically
At last month’s MicroCap Conference in Philadelphia, the technological prowess of OurPet’s Company (OTCQX: OPCO) was on display. A presentation…
Net Element, Inc. (NETE) Selects Conformance Technologies as Preferred Provider for Data Compliance Solutions
Before the opening bell, Net Element, Inc. (NASDAQ: NETE) announced its selection of Conformance Technologies, a fast-growing provider of operating…
Chanticleer Holdings, Inc. (HOTR) Preparing for Grand Opening of Little Big Burger in Portland, Oregon
Chanticleer Holdings, Inc. (NASDAQ: HOTR) kicked off November with the announcement that, during the fiscal quarter ended September 30, 2016,…
bBooth, Inc. (BBTH) Introduces Virtual Representatives to the Marketing Mix
Hollywood-based entertainment technology company bBooth, Inc. (OTCQB: BBTH) is set to disrupt the entire Software-as-a-Service (SaaS), Customer Relationship Management (CRM),…
Corbus Pharmaceuticals Holdings, Inc. (CRBP) is “One to Watch”
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical stage drug development company targeting rare, chronic, and serious inflammatory and fibrotic…